286610816	286610816	CD	B-NP	O
|	|	NN	I-NP	O
CCH	CCH	NN	I-NP	O
|	|	NN	I-NP	O
49352101	49352101	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1706879	1706879	CD	B-NP	O
|	|	CC	I-NP	O
4/9/2006	4/9/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
SEPSIS	SEPSIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/10/2006	6/10/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/10/2006	3/10/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
VERDUGO	VERDUGO	NNP	B-NP	O
,	,	,	O	O
MAX	MAX	NNP	B-NP	O
ARTHUR	ARTHUR	NNP	I-NP	O
MD	MD	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
Medicine	Medicine	NNP	B-NP	O
.	.	.	O	O

Mr.	Mr.	NNP	B-NP	O
Lyn	Lyn	NNP	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
hypoxia	hypoxia	NN	B-NP	O
and	and	CC	I-NP	O
hypotension	hypotension	NN	I-NP	O
initially	initially	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
.	.	.	O	O

He	He	PRP	B-NP	B-DNA
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
66-year-old	66-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
type	type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
CVAs	CVA	NNS	B-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
admitted	admit	VBN	I-VP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2006	2006	CD	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
middle	middle	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
spent	spend	VBD	B-VP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
felt	feel	VBD	B-VP	O
fine	fine	JJ	B-ADJP	O
since	since	IN	B-PP	O
then	then	RB	B-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
waxing	waxing	NN	I-NP	O
and	and	CC	I-NP	O
waning	waning	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
rigor	rigor	NN	B-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
difficulty	difficulty	NN	B-NP	O
walking	walk	VBG	B-VP	O
and	and	CC	I-VP	O
speaking	speak	VBG	I-VP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
to	to	TO	B-PP	O
101	101	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
short	short	JJ	B-ADJP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
blue	blue	JJ	B-NP	O
lips	lip	NNS	I-NP	O
,	,	,	O	O
hands	hand	VBZ	B-VP	O
per	per	IN	B-PP	O
his	his	PRP$	B-NP	O
family	family	NN	I-NP	O
.	.	.	O	O

EMS	EMS	NNS	B-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
O2	O2	NN	I-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
;	;	:	O	O
it	it	PRP	B-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
nonrebreather	nonrebreather	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
new	new	JJ	B-NP	O
left	left	JJ	I-NP	O
bundle-branch	bundle-branch	NN	I-NP	O
block	block	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
cath	cath	NN	B-NP	O
lab	lab	NN	I-NP	O
declined	decline	VBD	B-VP	O
to	to	TO	I-VP	O
intervene	intervene	VB	I-VP	O
because	because	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
tachycardic	tachycardic	JJ	B-ADJP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
demand	demand	VB	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
requiring	require	VBG	B-VP	O
fluids	fluid	NNS	B-NP	O
.	.	.	O	O

Subclavian	Subclavian	JJ	B-NP	O
line	line	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
3-vessel	3-vessel	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	B-protein
post	post	NN	I-NP	I-protein
CABG	CABG	NN	I-NP	I-protein
x1	x1	NN	I-NP	I-protein
in	in	IN	B-PP	O
1999	1999	CD	B-NP	O
,	,	,	O	O
SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
RCA	RCA	NN	B-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
NSTEMI	NSTEMI	NN	I-NP	O
in	in	IN	B-PP	O
1/22	1/22	CD	B-NP	O
with	with	IN	B-PP	O
Cypher	Cypher	NNP	B-NP	O
stent	stent	VBD	B-VP	O
to	to	TO	B-PP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
and	and	CC	O	O
Pixel	Pixel	NNP	B-NP	O
stent	stent	VBD	B-VP	O
to	to	TO	B-PP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
ostial	ostial	JJ	I-NP	O
D1	D1	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
NSTEMI	NSTEMI	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2004	2004	CD	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
Cypher	Cypher	NNP	I-NP	O
to	to	TO	B-PP	O
D1	D1	NN	B-NP	O
instent	instent	JJ	I-NP	O
restenosis	restenosis	NN	I-NP	O
and	and	CC	O	O
diffuse	diffuse	JJ	B-NP	O
left	left	JJ	I-NP	O
circ	circ	NN	I-NP	O
disease	disease	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
type	type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
St.	St.	NNP	B-NP	O
Jude	Jude	NNP	I-NP	O
33-mm	33-mm	JJ	I-NP	O
valve	valve	NN	I-NP	O
in	in	IN	B-PP	O
1999	1999	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
multiple	multiple	JJ	B-NP	O
CVAs	CVA	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
treatment	treatment	NN	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
after	after	IN	B-PP	O
failure	failure	NN	B-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
and	and	CC	O	O
prophylactic	prophylactic	JJ	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lovenox	Lovenox	NNP	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
subdural	subdural	JJ	I-NP	O
hematoma	hematoma	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
bur-hole	bur-hole	JJ	I-NP	O
drainage	drainage	NN	I-NP	O
in	in	IN	B-PP	O
1999	1999	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
seizure	seizure	NN	B-NP	O
disorder	disorder	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
carotid	carotid	NN	B-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
CEA	CEA	NN	I-NP	O
in	in	IN	B-PP	O
2002	2002	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
GERD	GERD	NN	B-NP	O
and	and	CC	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
sacral	sacral	JJ	B-NP	O
decubitus	decubitus	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
200	200	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	VBP	B-VP	O
20	20	CD	B-NP	O
daily	daily	JJ	I-NP	O
,	,	,	I-NP	O
Lovenox	Lovenox	NNP	I-NP	O
80	80	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
fenofibrate	fenofibrate	NN	B-NP	O
145	145	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
40	40	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
glipizide	glipizide	NN	B-NP	O
10	10	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Keppra	Keppra	NNP	B-NP	O
500	500	CD	I-NP	O
b.i.d.	b.i.d.	NNP	I-NP	O
,	,	,	I-NP	O
Benadryl	Benadryl	NNP	I-NP	O
25	25	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
itching	itch	VBG	B-NP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	I-NP	O
trazodone	trazodone	NN	I-NP	O
50	50	CD	I-NP	O
daily	daily	RB	I-NP	O
,	,	,	O	O
Zantac	Zantac	NNP	B-NP	O
150	150	CD	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
miconazole	miconazole	NN	B-NP	O
topical	topical	JJ	B-ADJP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Dilantin	Dilantin	NN	B-NP	B-protein
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
a	a	DT	B-NP	O
desquamating	desquamate	VBG	I-NP	O
rash	rash	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
,	,	,	O	O
his	his	PRP$	B-NP	O
temperature	temperature	NN	I-NP	O
was	be	VBD	B-VP	O
96.7	96.7	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
75	75	CD	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	O
98/54	98/54	CD	I-NP	O
,	,	,	O	O
breathing	breathe	VBG	B-VP	O
at	at	IN	B-PP	O
14	14	CD	B-NP	O
,	,	,	O	O
satting	satte	VBG	B-VP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
4	4	CD	B-NP	O
L	L	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Anicteric	Anicteric	JJ	B-ADJP	O
.	.	.	O	O

OP	OP	NN	B-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
exam	exam	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
crackles	crackle	NNS	B-NP	O
,	,	,	O	O
decreased	decrease	VBN	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bases	base	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
distant	distant	JJ	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
mechanical	mechanical	JJ	B-NP	O
S1	S1	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
jaw	jaw	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
abdomen	abdoman	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
dry	dry	JJ	I-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
rashes	rash	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
awake	awake	JJ	B-ADJP	O
but	but	CC	O	O
not	not	RB	B-ADJP	O
cooperative	cooperative	JJ	I-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
left-sided	left-sided	JJ	I-NP	O
facial	facial	JJ	I-NP	O
droop	droop	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
forearm	forearm	NN	B-NP	O
flexion	flexion	NN	I-NP	O
,	,	,	O	O
moving	move	VBG	B-VP	O
all	all	DT	B-NP	O
4	4	CD	I-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
admission	admission	NN	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
diffuse	diffuse	JJ	I-NP	O
bilateral	bilateral	JJ	I-NP	O
airspace	airspace	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
right	right	RB	B-ADVP	O
greater	great	JJR	I-ADVP	O
than	than	IN	B-PP	O
left	left	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
multilobar	multilobar	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
versus	versus	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
2005	2005	CD	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
LVEF	LVEF	NN	I-NP	B-protein
of	of	IN	B-PP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
kinesis	kinesis	NN	I-NP	O
of	of	IN	B-PP	O
septum	septum	NN	B-NP	O
,	,	,	O	O
inferior	inferior	JJ	B-NP	O
wall	wall	NN	I-NP	O
,	,	,	O	O
apical	apical	JJ	B-NP	O
lateral	lateral	JJ	I-NP	O
segment	segment	NN	I-NP	O
and	and	CC	O	O
mechanical	mechanical	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
76	76	CD	B-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
his	his	PRP$	B-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
faster	fast	JJR	B-ADJP	O
,	,	,	O	O
he	he	PRP	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	B-protein
bundle-branch	bundle-branch	NN	I-NP	I-protein
block	block	NN	I-NP	I-protein
.	.	.	O	O

COURSE	COURSE	NN	B-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
multilobar	multilobar	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
recent	recent	JJ	I-NP	O
admission	admission	NN	I-NP	O
for	for	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
appearance	appearance	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	B-ADVP	O
on	on	IN	B-PP	O
empiric	empiric	JJ	B-NP	O
ceftriaxone	ceftriaxone	NN	I-NP	O
,	,	,	O	O
azithromycin	azithromycin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
vancomycin	vancomycin	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
discontinued	discontinue	VBD	B-VP	O
the	the	DT	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
weaned	wean	VBD	B-VP	O
from	from	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
cleared	clear	VBN	B-VP	O
within	within	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

So	So	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
more	more	JJR	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
completed	complete	VBD	B-VP	O
a	a	DT	B-NP	O
short	short	JJ	I-NP	O
7-day	7-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
azithromycin	azithromycin	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
I.	I.	NNP	B-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
extensive	extensive	JJ	B-NP	O
CAD	CAD	NN	I-NP	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
CK	CK	NN	I-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
left	left	JJ	I-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
demand	demand	NN	I-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
enzymes	enzyme	NNS	I-NP	B-protein
were	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
troponin	troponin	NN	I-NP	O
remaining	remain	VBG	B-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
5	5	CD	B-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
MB	MB	NN	I-NP	B-protein
had	have	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
from	from	IN	B-PP	O
18	18	CD	B-NP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
rapidly	rapidly	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
cardiology	cardiology	NN	I-NP	O
consultants	consultant	NNS	I-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
demand	demand	NN	B-NP	O
ischemia	ischemia	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
bundle-branch	bundle-branch	NN	I-NP	O
block	block	NN	I-NP	O
was	be	VBD	B-VP	O
rate	rate	NN	B-NP	O
dependent	dependent	JJ	B-ADJP	O
and	and	CC	O	O
recommended	recommend	VBD	B-VP	O
continued	continue	VBN	B-NP	O
medical	medical	JJ	I-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
already	already	RB	B-ADVP	O
on	on	IN	B-PP	O
therapeutic-dose	therapeutic-dose	JJ	B-NP	O
Lovenox	Lovenox	NNP	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CVA	CVA	NN	B-NP	B-protein
.	.	.	O	O

II	II	CD	B-NP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
initially	initially	RB	B-ADVP	O
had	have	VBD	B-VP	O
hypertension	hypertension	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
unit	unit	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
resolved	resolve	VBN	B-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
appeared	appear	VBD	B-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
echo	echo	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

III	III	CD	B-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
exhibited	exhibit	VBD	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
left	left	JJ	I-NP	O
bundle-branch	bundle-branch	NN	I-NP	O
block	block	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
tachycardia	tachycardia	NN	B-NP	O
but	but	CC	O	O
decreased	decrease	VBN	B-NP	O
rate	rate	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
Initially	Initially	RB	B-ADVP	O
had	have	VBD	B-VP	O
bleeding	bleed	VBG	I-VP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
left	left	JJ	I-NP	I-DNA
subclavian	subclavian	JJ	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
;	;	:	O	O
it	it	PRP	B-NP	O
resolved	resolve	VBD	B-VP	O
.	.	.	O	O

Spoke	Spoke	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
vascular	vascular	JJ	I-NP	O
wervice	wervice	NN	I-NP	O
who	who	WP	B-NP	O
recommended	recommend	VBD	B-VP	O
holding	hold	VBG	I-VP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lovenox	Lovenox	NNP	B-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
line	line	NN	I-NP	O
was	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
line	line	NN	I-NP	O
was	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
successfully	successfully	RB	B-ADVP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
bleeding	bleeding	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
remained	remain	VBD	B-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
of	of	IN	B-PP	O
1.2	1.2	CD	B-NP	O
to	to	TO	B-PP	O
1.5	1.5	CD	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
CVAs	CVA	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
kept	keep	VBD	B-VP	O
him	him	PRP	B-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
treatment-dose	treatment-dose	JJ	I-NP	O
Lovenox	Lovenox	NN	I-NP	O
other	other	JJ	B-ADJP	O
than	than	IN	B-PP	O
being	be	VBG	B-VP	O
held	hold	VBN	I-VP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
remove	remove	VB	I-VP	O
the	the	DT	B-NP	O
line	line	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
seizure	seizure	NN	B-NP	O
disorder	disorder	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Keppra	Keppra	NNP	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
sundowning	sundowning	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
Zyprexa	Zyprexa	NN	B-NP	O
briefly	briefly	NN	I-NP	O
but	but	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Endo	Endo	NNP	B-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Vanzie	Vanzie	NNP	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
and	and	CC	O	O
lispro	lispro	NN	B-NP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
decided	decide	VBD	B-VP	O
to	to	TO	I-VP	O
send	send	VB	I-VP	O
him	him	PRP	B-NP	O
on	on	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
some	some	DT	B-NP	O
a.c.	a.c.	NN	I-NP	O
NovoLog	NovoLog	NNP	B-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

Mr.	Mr.	NNP	B-NP	O
Sindel	Sindel	NNP	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
services	service	NNS	B-NP	O
with	with	IN	B-PP	O
followup	followup	NN	B-NP	O
appointments	appointment	NNS	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Willie	Willie	NNP	I-NP	O
Saale	Saale	NNP	I-NP	O
on	on	IN	B-PP	O
3/30/2006	3/30/2006	CD	B-NP	O
at	at	IN	B-PP	O
1330	1330	CD	B-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Demaine	Demaine	NNP	I-NP	O
on	on	IN	B-PP	O
5/11/2006	5/11/2006	CD	B-NP	O
at	at	IN	B-PP	O
1550	1550	CD	B-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Malmanger	Malmanger	NNP	I-NP	O
on	on	IN	B-PP	O
11/8/2006	11/8/2006	CD	B-NP	O
at	at	IN	B-PP	O
1400	1400	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	B-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
4	4	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
headache	headache	NN	B-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Dulcolax	Dulcolax	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lovenox	Lovenox	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
fenofibrate	fenofibrate	NN	B-NP	O
145	145	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
NovoLog	NovoLog	NNP	B-NP	O
12	12	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
with	with	IN	B-PP	O
each	each	DT	B-NP	O
meal	meal	NN	I-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
44	44	CD	I-NP	O
mg	mg	NN	I-NP	O
each	each	DT	B-NP	O
night	night	NN	I-NP	O
,	,	,	O	O
Atrovent	Atrovent	NNP	B-NP	O
nebs	neb	VBZ	B-VP	O
0.5	0.5	CD	B-NP	O
mg	mg	NN	I-NP	O
4	4	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
,	,	,	O	O
Keppra	Keppra	NNP	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Toprol-XL	Toprol-XL	NNP	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Zantac	Zantac	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Lipitor	Lipitor	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
2-8426881	2-8426881	CD	B-NP	O
HFFocus	HFFocus	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
BERTINETTI	BERTINETTI	NNP	B-NP	O
,	,	,	O	O
HUGH	HUGH	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BELSTAD	BELSTAD	NNP	B-NP	O
,	,	,	O	O
DARIN	DARIN	NNP	B-NP	O
MYRON	MYRON	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
8732026	8732026	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
2/5/06	2/5/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
2/5/06	2/5/06	CD	B-NP	O

